3195 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 64 | next »
Genei
Gene descriptioni x
Protein classi x
Tissue
Cell
Pathology
Subcellular locationi x
Prognostic p-valuei x
RNA cancer categoryi x
RNA tissue categoryi x
A2ML1Alpha-2-macroglobulin like 1Predicted intracellular proteins
Predicted secreted proteins
Tissue enhancedTissue enriched
AADACArylacetamide deacetylaseEnzymes
Predicted intracellular proteins
Ovarian cancer: 5.58e-6
Stomach cancer: 2.19e-4
Pancreatic cancer: 5.02e-4
Tissue enrichedGroup enriched
AARDAlanine and arginine rich domain containing proteinPredicted intracellular proteins
Lipid dropletsTissue enrichedTissue enriched
AATKApoptosis associated tyrosine kinaseEnzymes
Predicted intracellular proteins
Predicted membrane proteins
MitochondriaMixedTissue enhanced
ABCA4ATP binding cassette subfamily A member 4Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Lung cancer: 2.45e-4
Urothelial cancer: 2.72e-4
Tissue enhancedTissue enhanced
ABCB1ATP binding cassette subfamily B member 1Cancer-related genes
CD markers
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Focal adhesion sites
Cytosol
Renal cancer: 2.95e-4
Pancreatic cancer: 3.33e-4
Tissue enhancedTissue enhanced
ABCB9ATP binding cassette subfamily B member 9Predicted intracellular proteins
Predicted membrane proteins
Transporters
VesiclesGlioma: 4.62e-4
MixedTissue enhanced
ABCC3ATP binding cassette subfamily C member 3Cancer-related genes
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneRenal cancer: 4.68e-6
Pancreatic cancer: 9.57e-4
MixedMixed
ABCC4ATP binding cassette subfamily C member 4Plasma proteins
Predicted membrane proteins
Transporters
Renal cancer: 2.25e-10
Endometrial cancer: 9.89e-4
Tissue enrichedTissue enhanced
ABCC6ATP binding cassette subfamily C member 6Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Plasma membraneLiver cancer: 3.82e-4
Tissue enhancedTissue enhanced
ABCG2ATP binding cassette subfamily G member 2 (Junior blood group)Cancer-related genes
CD markers
Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Plasma membrane
MixedTissue enhanced
ABHD12BAbhydrolase domain containing 12BPredicted intracellular proteins
NucleusTissue enrichedTissue enriched
ABI3BPABI family member 3 binding proteinPlasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 6.14e-4
MixedMixed
ABLIM2Actin binding LIM protein family member 2Predicted intracellular proteins
Nucleoplasm
Mitochondria
MixedTissue enhanced
ABOABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferasePredicted membrane proteins
MixedTissue enhanced
ACADLAcyl-CoA dehydrogenase, long chainDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Renal cancer: 1.58e-11
Group enrichedTissue enhanced
ACBD7Acyl-CoA binding domain containing 7Predicted intracellular proteins
Vesicles
Cytosol
MixedTissue enriched
ACE2Angiotensin I converting enzyme 2Enzymes
FDA approved drug targets
Predicted membrane proteins
Renal cancer: 2.12e-5
Liver cancer: 4.21e-4
Tissue enhancedGroup enriched
ACER2Alkaline ceramidase 2Enzymes
Predicted membrane proteins
Tissue enhancedGroup enriched
ACHEAcetylcholinesterase (Cartwright blood group)Blood group antigen proteins
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Renal cancer: 3.88e-5
Glioma: 7.16e-4
MixedTissue enhanced
ACKR2Atypical chemokine receptor 2G-protein coupled receptors
Predicted membrane proteins
Nucleoplasm
Vesicles
Cytosol
MixedTissue enhanced
ACOT11Acyl-CoA thioesterase 11Predicted intracellular proteins
CytosolRenal cancer: 3.07e-8
Colorectal cancer: 9.37e-4
MixedMixed
ACOX2Acyl-CoA oxidase 2Enzymes
Predicted intracellular proteins
Vesicles
Cytosol
Tissue enhancedTissue enhanced
ACPPAcid phosphatase, prostateCancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enrichedTissue enriched
ACRBPAcrosin binding proteinPredicted secreted proteins
Nucleoplasm
Vesicles
MixedTissue enriched
ACSM1Acyl-CoA synthetase medium-chain family member 1Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Group enrichedTissue enriched
ACSM3Acyl-CoA synthetase medium-chain family member 3Enzymes
Predicted intracellular proteins
Renal cancer: 9.88e-6
Ovarian cancer: 1.97e-4
MixedTissue enhanced
ACSS3Acyl-CoA synthetase short-chain family member 3Enzymes
Predicted membrane proteins
MitochondriaRenal cancer: 0.00e+0
MixedMixed
ACTA1Actin, alpha 1, skeletal muscleDisease related genes
Plasma proteins
Predicted intracellular proteins
Group enrichedTissue enriched
ACTL10Actin like 10Predicted secreted proteins
MixedTissue enriched
ACTL8Actin like 8Predicted intracellular proteins
CytosolEndometrial cancer: 1.62e-6
Head and neck cancer: 7.02e-4
MixedTissue enriched
ACTR3CARP3 actin-related protein 3 homolog CPredicted intracellular proteins
MixedTissue enriched
ACTRT3Actin related protein T3Predicted intracellular proteins
NucleoplasmEndometrial cancer: 4.11e-4
MixedTissue enriched
ACY3Aminoacylase 3Enzymes
Predicted intracellular proteins
Endometrial cancer: 4.80e-4
MixedTissue enhanced
ADAM12ADAM metallopeptidase domain 12Predicted membrane proteins
Predicted secreted proteins
Transporters
Plasma membraneRenal cancer: 2.39e-14
MixedTissue enriched
ADAM23ADAM metallopeptidase domain 23Predicted intracellular proteins
Predicted membrane proteins
MixedGroup enriched
ADAM28ADAM metallopeptidase domain 28Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Plasma membrane
Mitochondria
Endometrial cancer: 3.17e-4
MixedTissue enhanced
ADAM33ADAM metallopeptidase domain 33Disease related genes
Predicted membrane proteins
Predicted secreted proteins
Nuclear speckles
Plasma membrane
MixedMixed
ADAMTS12ADAM metallopeptidase with thrombospondin type 1 motif 12Plasma proteins
Predicted secreted proteins
Nucleoli
Mitochondria
Urothelial cancer: 6.78e-4
MixedMixed
ADAMTS13ADAM metallopeptidase with thrombospondin type 1 motif 13Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
MixedMixed
ADAMTS14ADAM metallopeptidase with thrombospondin type 1 motif 14Cancer-related genes
Plasma proteins
Predicted secreted proteins
CytosolMixedTissue enhanced
ADAMTS15ADAM metallopeptidase with thrombospondin type 1 motif 15Predicted secreted proteins
CytosolUrothelial cancer: 5.63e-5
Glioma: 9.00e-4
Lung cancer: 9.72e-4
MixedTissue enhanced
ADAMTS16ADAM metallopeptidase with thrombospondin type 1 motif 16Predicted secreted proteins
Renal cancer: 3.29e-5
MixedTissue enhanced
ADAMTS17ADAM metallopeptidase with thrombospondin type 1 motif 17Disease related genes
Predicted intracellular proteins
Predicted secreted proteins
NucleusMixedMixed
ADAMTS18ADAM metallopeptidase with thrombospondin type 1 motif 18Cancer-related genes
Disease related genes
Predicted intracellular proteins
Predicted secreted proteins
MixedTissue enriched
ADAMTS5ADAM metallopeptidase with thrombospondin type 1 motif 5Cancer-related genes
Predicted secreted proteins
NucleoplasmRenal cancer: 2.46e-4
Thyroid cancer: 8.54e-4
MixedTissue enhanced
ADAMTS6ADAM metallopeptidase with thrombospondin type 1 motif 6Cancer-related genes
Predicted secreted proteins
MixedTissue enhanced
ADAMTS7ADAM metallopeptidase with thrombospondin type 1 motif 7Plasma proteins
Predicted secreted proteins
VesiclesStomach cancer: 9.53e-4
MixedTissue enhanced
ADAMTSL1ADAMTS like 1Predicted intracellular proteins
Predicted secreted proteins
MixedTissue enhanced
ADAMTSL3ADAMTS like 3Predicted secreted proteins
VesiclesMixedMixed
Page of 64 | next »